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We used yeast “two-hybrid” screening to isolate
cDNA-encoding proteins interacting with the N-termi-
nal domain of the Ras nucleotide exchange factor
CDC25Mm. Three independent overlapping clones were
isolated from a mouse embryo cDNA library. The full-
length cDNA was cloned by RACE-polymerase chain re-
action. It encodes a large protein (1080 amino acids)
highly homologous to the human deubiquitinating en-
zyme hUBPy and contains a well conserved domain typ-
ical of ubiquitin isopeptidases. Therefore we called this
new protein mouse UBPy (mUBPy). Northern blot anal-
ysis revealed a 4-kilobase mRNA present in several
mouse tissues and highly expressed in testis; a good
level of expression was also found in brain, where
CDC25Mm is exclusively expressed. Using a glutathione
S-transferase fusion protein, we demonstrated an “in
vitro” interaction between mUBPy and the N-terminal
half (amino acids 1–625) of CDC25Mm. In addition “in
vivo” interaction was demonstrated after cotransfection
in mammalian cells. We also showed that CDC25Mm, ex-
pressed in HEK293 cells, is ubiquitinated and that the
coexpression of mUBPy decreases its ubiquitination. In
addition the half-life of CDC25Mm protein was consid-
erably increased in the presence of mUBPy. The specific
function of the human homolog hUBPy is not defined,
although its expression was correlated with cell prolif-
eration. Our results suggest that mUBPy may play a role
in controlling degradation of CDC25Mm, thus regulating
the level of this Ras-guanine nucleotide exchange factor.
Ras-guanine nucleotide exchange factors (GEFs)1 are pro-
teins that stimulate the exchange of guanine nucleotides (GDP/
GTP) on Ras proteins. We have previously cloned a mouse
brain-specific Ras-GEF, called CDC25Mm (1–2) or Ras-GRF1.
CDC25Mm is a large protein (140 kDa) that contains a Ras-
exchange domain in the C-terminal region and several differ-
ent domains in the large N-terminal region, namely two PH
(pleckstrin homology) domains, one DH (Dbl homology) do-
main, and an illimaquinone (IQ) domain (2–3). In addition a
coiled-coil region and a PEST sequence were identified (4).
Several evidences indicate that the large N-terminal region
of CDC25Mm has a regulatory function and may interact with
other cellular components. We have previously shown that the
expression in mouse fibroblasts of a truncated form of
CDC25Mm, lacking the Ras exchange domain, behaves as a
dominant negative protein (5). In addition PH domains could
interact with phospholipids (6) and with the  subunits of
heterotrimeric G proteins (7), whereas the IQ domain binds
calmodulin (3, 8) and is thought to be responsible for the
activation of GEF activity by calcium (3). Further evidence that
the N-terminal region of CDC25Mm protein is involved in spe-
cific protein interaction(s) also comes from the work of Kiyono
et al. (9) in which it was shown that CDC25Mm/Ras-GRF1 was
able to activate Rac1 and that for this activity a functional DH
domain is required. Moreover the DH domain was required for
homodimerization of Ras-GRF1 or for heterodimerization with
Ras-GRF2 (10)
However, so far, only the specific interaction CDC25Mm/cal-
modulin has been demonstrated in vivo (3, 8). In an effort to
identify mammalian proteins that could interact with the large
N-terminal region of CDC25Mm, we used a yeast “two-hybrid”
system for the screening of mouse embryo cDNA libraries (11).
Here we report that the cloning and characterization of a cDNA
that was positive in this screening. This cDNA was found to
encode a new deubiquitinating enzyme belonging to the ubiq-
uitin isopeptidase family (UBPs) and was highly homologous to
the recently identified human enzyme hUBPy (12); therefore
we called this new cDNA mouse UBPy (mUBPy).
EXPERIMENTAL PROCEDURES
Two-hybrid Screening—The system developed by Vojtek et al. (11)
was used for the two-hybrid screening. Two mouse embryo cDNA li-
braries (9.5 and 10.5 dpc) constructed in pVP16 vector (a gift of Stan
Hollenberg) were used. Three bait plasmids were prepared by cloning
fragments of the N-terminal region of CDC25Mm in the pBTM116 vec-
tor, which contained the Lex-A DNA binding domain (11).
The first bait plasmid (pBTEE) contains 1877 bp of CDC25Mm IV
(2), which corresponds to the first 625 amino acids; this region includes
the first PH domain, the IQ motif, the Dbl homology (DH) domain, and
the second PH domain. pBTES contains 1519 bp of CDC25Mm IV,
corresponding to the first 506 amino acids, and lacks the second PH
domain, whereas pBTEP contains 436 bp, corresponding to the first 145
amino acids, and contains only the first PH domain.
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The yeast strain L40 (MATa, his3, trp1, leu2, ade2,
LYS2::(lexAop)4-HIS3, URA3::(lexAop)8-lacZ) was transformed with the
bait vector (initially pBTEE) and with the mouse embryo cDNA librar-
ies. Selection was performed as described by Vojtek et al. (11) in selec-
tive minimal plates containing 5 mM 3-aminotriazole. Positive clones,
obtained only by the 10.5-dpc library, were also tested for -galactosid-
ase activity. Plasmids were recovered from positive clones and used for
a new round of screening to test their positivity. Positive clones were
sequenced and then tested with the other plasmids containing reduced
regions of CDC25Mm (pBTES and pBTEP).
RACE-PCR, Cloning, Plasmids, Sequencing, and Northern Blot Hy-
bridization—RACE reactions were done using Marathon-Ready cDNA
(CLONTECH) from 11.5-dpc mouse embryo and a mix of polymerases
(Advantage Klen-Taq Mix, CLONTECH) suitable for amplification of
long regions of DNA with high fidelity. The PCR conditions were set and
performed according to the protocols given by CLONTECH. Four oligo-
nucleotides were used, two for 3 RACE and two for 5 RACE using a
nested PCR procedure to obtain an increased specificity. For 3 RACE,
the external primer was GSS1 (5-GCTCAGCGAGAACCTTTGAC-
GAGAGC-3), and the internal one was GSS2 (5-CCTGAAATGGCTC-
CTCGTCTGCACC-3). For 5 RACE, the external primer was GSA1
(5-GGTGCAGACGAAGGAGCCATTTCAGG-3), and the internal one
was GSA2 (5-GCTCTCGTCAAAGGTTCTCGCTGAGC-3).
Two oligonucleotides (i.e. GSS1 and GSA1) were also used in a
control reaction to verify the presence of the specific cDNA in the pool.
Positivity was revealed by a 176-bp fragment.
The amplification products of 3 and 5 RACE were cloned in pMOS-
Blue (Amersham Pharmacia Biotech) and sequenced. Three clones were
sequenced both for 3 and 5 amplification products.
Sequencing was performed on both strands using the Taq Dye Ter-
minator Cycle Sequencing Kit (Applied Biosystems) with universal and
walking primers and using an automated DNA sequence analyzer (Ap-
plied Biosystems 373A). The full-length cDNA was obtained by using
the unique NdeI site present in the overlapping region and was sub-
cloned in pCDNA3 vector (Invitrogen).
pCDNA3-mUBPy-HA vector was prepared by ligation of a cDNA
fragment of 2.5 kilobase pairs comprising the coding sequence of aa
542–1080 of mUBPy in pBSKSII-HA vector (Stratagene), and then a
SphI-EcoRI fragment coding for a fusion between HA tag and the aa
542–1080 of mUBPy was subcloned in pCDNA3 plasmid. HA-ubiquitin
vector and pCDNA3-hUBPy plasmid were obtained by G. Draetta (12).
For Northern blots, polyadenylated RNAs from mouse tissues (total
mouse RNA, Ambion) were separated on agarose-formaldehyde gels (5
g/lane), blotted to a Hybond-N nylon membrane (Amersham Pharma-
cia Biotech), and hybridized with a digoxygenin-labeled riboprobe. Sig-
nals were detected with the Nucleic Acid Detection kit (Roche Molecular
Biochemicals). The probe was prepared by subcloning a fragment of
mUBPy cDNA in a pGEM3z vector (Promega) and in vitro transcription
with T7 RNA polymerase and digoxygenin-labeled UTP (Roche Molec-
ular Biochemicals) according to the manufacturer’s instructions.
Sequence Analysis—The searches for open reading frames and their
conceptual translations were performed with DM software (13). The
homology search was done at the BLAST (14) server at NCBI (www.
ncbi.nlm.nih.gov/BLAST/). Protein alignments were done with MACAW
(15), while the search for motifs in protein was done with Profilescan at
the Expasy server (www.expasy.ch/).
Recombinant Protein Production and Preparation of Polyclonal An-
tibodies—The cDNA contained in one of the positive clones (6/12) was
subcloned in the SmaI site of the Escherichia coli expression vector
pGEX-2T (Amersham Pharmacia Biotech) to obtain a fusion protein
between GST and 119 amino acids of mUBPy corresponding to position
542 to 660 of the whole protein. E. coli DH5 cells bearing the vector for
fusion protein were grown in LB broth, induced with 0.1 mM isopropyl-
1-thio--D-galactopyranoside at 28 °C for 3 h, and collected for protein
extraction. Fusion protein was purified with glutathione-Sepharose
resin as described (16). About 1 mg of purified fusion protein (GST-
mUBPy542–660) was used to immunize New Zealand rabbits. Polyclonal
antibodies were then affinity-purified using a GST-coupled Affi-Gel-10
column (Bio-Rad) as described (17). For pull-down experiments, the
GST-mUBPy542–660 fusion protein was used, coupled to glutathione-
Sepharose beads.
Western Blotting—Tissues from adult CD1 mice (Charles River,
Calco (LC), Italy) were mechanically homogenized with 4 volumes of
Tris (0.125 M, pH 6.8) and SDS (7% w/v). The homogenate was further
sonicated in ice and centrifuged (20,000  g for 10 min); the solubilized
proteins were separated on SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) and transferred to nitrocellulose. Membranes were probed
with affinity-purified anti-mUBPy polyclonal antibodies (diluted
1:1000). Bound antibodies were detected with peroxidase-conjugated
goat anti-rabbit immunoglobulins and revealed by the ECL detection
system (Amersham Pharmacia Biotech).
Cells cultures were harvested, washed with phosphate-buffered sa-
line, and lysed in RIPA buffer (Tris-HCl, 50 mM; NaCl, 150 mM; sodium
deoxycholate, 0.5% w/v; SDS, 0.1% w/v; Triton X-100, 1% w/v) contain-
ing protease inhibitors (leupeptin, 1 M; aprotinin, 0.1 M; sodium
vanadate, 0.1 mM; phenylmethylsulfonyl fluoride, 0.1 mM). Aliquots of
cleared cell lysate were separated on SDS-polyacrylamide gels, trans-
ferred to nitrocellulose, and immunoblotted with anti-mUBPy
antibodies.
Cell Culture and Transfection—NIH-3T3, COS7, and Hek-293 cells
were cultured in Dulbecco’s modified Eagle’s medium supplemented
with 10% fetal bovine serum. Subconfluent cells were transfected using
the LipofectAMINE (Life Technologies, Inc.) method according to the
protocol of the manufacturer.
Pull-down Experiments—48 h after transfection, COS7 cells were
harvested, washed with phosphate-buffered saline, and lysed in RIPA
buffer or in lysis buffer (HNGT) (Hepes, 25 mM; NaCl, 50 mM; glycerol,
10% w/v; Triton X-100, 1% w/v). The buffers contained protease
inhibitors.
Aliquots of lysates (450 l) were then incubated with 50 l of gluta-
thione-Sepharose resin loaded either with GST-mUBPy525–660 fusion
protein or with GST alone for 2 h at 4 °C. After incubation, the resin
was recovered by gentle centrifugation and washed five times with the
incubation buffer (RIPA or HGNT). At the end, the resin was treated
with 30 l of 2 SDS sample buffer and boiled for 10 min, and the
recovered proteins were used for Western blot analysis.
Coimmunoprecipitation and Immunoblotting—48 h after transfec-
tion, cells (COS7 or Hek-293) were harvested and lysed in 500 l/plate
(100 mm) of an ice-cold HNGT buffer as described (18). Immunoprecipi-
tation from cleared lysates was performed with monoclonal anti-HA-11
antibody (BAbCO) or with anti-mUBPy polyclonal antibodies for 1 h at
4 °C. Immunocomplexes were recovered with protein G-Sepharose or
with protein A-Sepharose (Sigma) for 1 h at 4 °C and then resuspended
in SDS sample buffer and analyzed by immunoblot analysis. Briefly 1⁄50
of cleared cell lysates and the immunoprecipitates were resolved by 10%
SDS-PAGE and transferred to nitrocellulose membranes. Membranes
were probed with anti Ras-GRF1 (C-20, Santa Cruz, CA) or with poly-
clonal anti-mUBPy raised in our laboratory. Immunocomplexes were
detected by enhanced chemiluminescence (Amersham Pharmacia Bio-
tech) using goat anti-rabbit antiserum coupled to horseradish peroxi-
dase as secondary antibodies (Cappel).
Deubiquitination Assays—We used a mouse testis extract as a source
of ubiquitinated protein as described in Ref. 19 with minor modifica-
tions. The cleared extracts were dialyzed against Tris-HCl 50 mM,
MgCl2 5 mM, and dithiothreitol 2 mM. The sample was then centrifuged
and washed several times in a Centricon-3 concentrator (Amicon) to
remove residual N-ethylmaleimide (12). Aliquots (50 g) of the proteins
were then incubated with immunoprecipitates (anti-HA antibodies)
from COS7 cells transfected with pCDNA3-mUBPy-HA vector at 37 °C
and processed as described in Ref. 19 using anti-ubiquitin antibodies
(Sigma).
In Vivo Ubiquitination of CDC25Mm—Hek-293 cells transfected with
the different plasmids (as reported in the figure legends) were lysed in
RIPA buffer. Immunoprecipitation from the same amount of total pro-
tein was performed with antibodies against Ras-GRF1 or anti-HA
(BAbCO). Immunocomplexes were recovered with protein G-Sepharose
(for anti-HA monoclonal antibodies) or protein A-Sepharose (for Ras-
GRF1 antibodies) and analyzed in Western blotting with the different
primary antibodies and then revealed with the corresponding second-
ary antibody and the ECL system.
Determination of Stability of CDC25Mm Protein—Hek-293 cells were
transiently transfected with 1 g of pCDNA3-CDC25Mm alone and then
cotransfected with 1.5 g of pCDNA3-mUBPy or with 1.5 g of
pCDNA3-human UBPy antisense (12). After 24 h, cells were washed
two times with minimum Eagle’s medium without methionine. Cells
were then incubated for 2 h with minimum Eagle’s medium without
methionine with [35S]methionine (100 C/60-mm dish), Hepes 25 mM,
and fetal calf serum 0.1%. After the incubation, cells were washed two
times with Dulbecco’s modified Eagle’s medium and further incubated
with Dulbecco’s modified Eagle’s medium supplemented with fetal bo-
vine serum 10%.
At the appropriate time, cells were rinsed in phosphate-buffered
saline and lysed in RIPA buffer, and the lysates were clarified. Immu-
noprecipitation from lysates was performed in the presence of Ras-
GRF1 antibody (Sigma) for 2 h at 4 °C, and the immunocomplexes were
recovered with protein A (Sigma) for 1 h at 4 °C with gentle rotation.
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Equal numbers of trichloroacetic acid-precipitable counts from cell ex-
tracts were immunoprecipitated.
The immunoprecipitates were washed three times with RIPA buffer
solution and then resuspended in 50 l of SDS-sample buffer and
separated by SDS-PAGE. The dry gels were exposed to x-ray films
(Amersham Pharmacia Biotech), and the intensity of specific bands was
analyzed by densitometry with NIH-Image software.
RESULTS
Screening for Proteins Interacting with the N-terminal
Region of CDC25Mm, Identification and Cloning of Mouse
UBPy—We used the N-terminal region (first 625 aa) of
CDC25Mm as a bait for a yeast two-hybrid screening. This
fragment comprises all the identified motifs except the cata-
lytic one, i.e. the first PH domain, the IQ domain, and the
DH-PH module, and it is the same region that, when expressed
in mammalian cells, behaves as a dominant negative protein
(5). For the screening, we used two different mouse embryo
cDNA libraries in pVP16 vector given by S. Hollenberg (11)
After two rounds of selection, we identified three “true” pos-
itive clones, all derived from the 10.5-dpc cDNA library. These
clones contained small cDNA inserts (about 400 bp), which
shared a common overlapping region of 300 bp. The largest
clone (called 6/12) was further characterized for its ability to
interact in yeast with different shorter regions of CDC25Mm. A
positive interaction was obtained with pBTES plasmid contain-
ing the first 506 aa of CDC25Mm and thus lacking the second
PH domain, whereas no interaction was observed with pBTEP
plasmid that contains only the first PH domain of CDC25Mm
(not shown). On the basis of these results, we can conclude that
the region of CDC25Mm between aa 145 and aa 506, containing
the IQ motif and the DH domain, is required for this in vivo
interaction. The sequence of the 6/12 clone revealed an open
reading frame (3-5 open) encoding a short proline-rich
polypeptide (119 aa) homologous to a small central region of
a human gene product called hUBPy, originally reported to
encode a putative deubiquitinating enzyme (20) and recently
demonstrated to be actually a deubiquitinase (12).
The full-length mouse cDNA was cloned by RACE-PCR using
a mouse embryo-cDNA (Marathon-Ready cDNA, CLONTECH)
starting from this central region. Several clones were obtained
both for the 3 region and the 5 region and were completely
sequenced. The 3970-bp cDNA contains a complete open read-
ing frame of 3240 nucleotides encoding a 1080 aa protein, 18 bp
upstream the putative AUG start codon and 713 bp down-
stream the stop codon (Fig. 1). Because the open reading frame
shared a great homology (higher than 90%) with the hUBPy,
we called this new mouse protein mouse UBPy (mUBPy). The
homology is very high in the C-terminal region (97% identity
between aa 591–1080) that contains the typical hallmarks of
the UBP family of deubiquitinating enzymes, i.e. a well con-
served UCH-2 domain (aa 739–1072, Profilescan) with the
characteristic cysteine and histidine boxes (21, 22). The N-
terminal part of mUBPy also contains a highly homologous
region (88% identity aa 1–346) followed by a region of lower
homology (68% identity aa 346–590). A search for motifs in this
FIG. 1. Amino acid sequence of
mUBPy predicted open reading
frame and comparison with hUBPy.
The sequence in bold is that of the 6/12
clone isolated from two-hybrid screening.
The underlined region identifies Cys and
His boxes typical of deubiquitinating en-
zymes (21, 22); the dotted underlined re-
gion (aa 198–311) represents the rho-
danese/cdc25 fold homology (23). The
sequence was deposited in GenBankTM,
accession number AF057146. The align-
ment between hUBPy (12) and mUBPy
was done with Macaw (15).
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N-terminal region revealed only a highly conserved Rhodanese/
cdc25 fold (aa 198–311) (23). Interestingly the Rhodanese/
cdc25 fold has been found in the noncatalytic region of several
yeast ubiquitin hydrolases (yeast Ubp4, 5 and 7), in the non-
catalytic domain of dual specificity MAPK-phosphatases, and
in the yeast phosphotyrosine phosphate-phosphatase (23).
Other interesting features of mUBPy protein are the presence
of two long proline-rich regions (aa 300–450 and aa 560–740,
respectively), which contain several PEST-like motifs, and two
coiled-coil regions (aa 95–140 and 460–500).
Expression of mUBPy in Mouse Tissues—The human homo-
log hUBPy was initially identified as the predicted product of a
cDNA found in myeloblasts (20). Successively, Naviglio et al.
(12) found the protein in several human cell lines (human
fibroblasts WI-38, osteosarcoma U2OS, HeLa cells, etc.).
Northern blot analysis performed on RNA extracted from
several mouse tissues evidenced the presence of a 4-kilobase
mUBPy mRNA in most of the probed tissues (Fig. 2A). As
expected, this mRNA was also present in mouse embryo and in
adult mouse brain; however, mUBPy mRNA was found to be
particularly abundant in testis.
Rabbit polyclonal antibodies were raised against a GST fu-
sion protein (containing 119 aa of mUBPy) expressed in E. coli.
The antiserum was treated with immobilized GST to remove
the anti-GST component and then used for Western blot
experiments.
An immunoscreening of mouse tissues revealed the presence
of a strong specific immunoreactive band of 120 kDa (in agree-
ment with the expected molecular size of the mUBPy open
reading frame: 122,579 Da) in mouse brain and testis homoge-
nates (Fig. 2B). A lower signal was observed in pancreas, lung,
small intestine, and placenta homogenates, whereas a barely
detectable signal was present in liver, spleen, kidney, and
heart (Fig. 2B). These results are generally in agreement with
the results obtained with Northern blot experiments. Therefore
the mUBPy protein is expressed at a very low level in most of
the adult mouse tissues with a strong expression in brain and
testis only. Moreover, mUBPy is not an easily soluble protein
because to detect it in most tissues, we needed strong detergent
conditions (i.e. 7% SDS). When a mild extraction procedure (1%
Triton X-100) was used, mUBPy could be detected only in brain
and testis (not shown). Since the human homolog hUBPy is
expressed in several cell lines (12), we also looked for the
expression of the mUBPy protein in mouse fibroblasts; more-
over we also probed two human cell lines with our antibodies.
A 120-kDa band was detected in the mouse NIH-3T3 fibro-
blasts extract (Fig. 2C, lanes 1 and 2); however, no difference
was observed between proliferating and density-arrested NIH-
3T3 fibroblasts. In addition a sharp 130-kDa band was detected
in both Hek-293 cells and SN-K-BE neuroblastoma cells, indi-
cating that our antibodies also recognize the human hUBPy
protein. This was not unexpected because the protein region we
used for the preparation of anti-mUBPy polyclonal antibodies
contains a large amino acid sequence (aa 592–657 of mUBPy,
see Fig. 1), which is identical in the two proteins.
mUBPy Is a Deubiquitinating Enzyme—Since mUBPy has a
high homology with hUBPy that has been demonstrated to
have a UBP (ubiquitin-isopeptidase) activity (12), we expected
that also mUBPy has an UBP activity. To verify this, we used
a mouse testis protein extract, pretreated with N-ethylmaleim-
ide, as a source of ubiquitinated proteins as reported by Lin et
al. (19). As shown in Fig. 3, the addition of HA-immunoprecipi-
tates from COS7 cells transfected with HA-tagged mUBPy (aa
542–1080) expressing vector greatly reduced the amount of
ubiquitinated protein recognized by anti-ubiquitin antibodies,
FIG. 2. Expression of mUBPy in mouse tissues and cell lines. A,
Northern blot analysis. 5 g of total RNA extracted from various mouse
tissues were separated on agarose-formaldehyde gels, blotted to a nylon
membrane, and hybridized with a digoxygenin-labeled mUBPy ribo-
probe. Signals were detected with the Nucleic Acid Detection Kit (Roche
Molecular Biochemicals). Lane 1, liver; lane 2, lung; lane 3, thymus;
lane 4, heart; lane 5, 11.5-dpc embryo; lane 6, spleen; lane 7, testis; lane
8, ovary; lane 9, kidney; lane 10, brain. The amount of RNA loaded in
each lane was comparable, as indicated by staining of the gel with
ethidium bromide (not shown). B, total proteins extracted from adult
mouse tissues, separated on SDS-PAGE 7% gels, blotted to nitrocellu-
lose, and probed with anti-mUBPy antibodies. A strong 120-kDa band
was observed in brain and testis. About 50 g of protein were loaded in
each lane. Lane 1, brain; lane 2, lung; lane 3, heart; lane 4, liver; lane 5,
spleen; lane 6, gut; lane 7, kidney; lane 8, pancreas; lane 9, ovary; lane
10, placenta; lane 11, testis. C, proteins extracted from cultured cells,
separated on SDS-PAGE gels, blotted to nitrocellulose, and probed with
anti-mUBPy antibodies. Lane 1, growing NIH-3T3; lane 2, confluent
NIH-3T3; lane 3, human neuroblastoma cells SK-N-BE; lane 4, human
Hek-297 cells. About 50 g of protein were loaded in each lane.
FIG. 3. mUBPy (aa 542–1080), expressed in COS7 cells, can
remove ubiquitin from endogenous ubiquitinated proteins.
Mouse testis extracts were prepared by homogenizing testes in the
presence of 20 mM N-ethylmaleimide to inactivate endogenous deubiq-
uitinating enzymes (19). Soluble fractions were dialyzed against 50 mM
Tris (pH 8), 5 mM MgCl2, and 2 mM dithiothreitol and then centrifuged
and washed four times in a Centricon-3 concentrator to remove residual
N-ethylmaleimide. Aliquots containing 50 g of total proteins were
incubated for 15 or 30 min with an HA-immunoprecipitate obtained
from COS7 cells transfected with pCDNA3-mUBPy-HA vector (4 g/
100-mm plate) expressing mUBPy 542–1080 tagged with HA epitope. The
immunoprecipitates of cleared lysate obtained from two dishes were
washed three times in HNGT buffer, and the equal aliquots (about 1⁄4 of
the total) were used for each assay. As a control, an immunoprecipitate
was washed in the presence of 20 mM N-ethylmaleimide ( NEM). At
the indicated times, samples were quenched with SDS-sample buffer
and analyzed by immunoblotting with anti-ubiquitin antibodies.
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indicating that mUBPy can deubiquitinate ubiquitin from high
molecular weight ubiquitinated proteins.
Interaction of mUBPy with CDC25Mm—We have previously
identified mUBPy in a two-hybrid screening for protein inter-
action with the Ras-GEF CDC25Mm. It was, however, impor-
tant to confirm this interaction directly in vitro and succes-
sively in an in vivo assay using mammalian cells.
A GST fusion protein containing the 119 aa of the clone 6/12
found to be positive in the yeast two-hybrid screening was
tested for in vitro interaction with the N-terminal region of
CDC25Mm by pull-down experiments. As shown in Fig. 4, a
specific interaction with the CDC25Mm N-terminal fragment
can be revealed. This result is in agreement with that obtained
by the yeast two-hybrid system.
To validate the above results, we tested the in vivo interac-
tion between CDC25Mm and mUBPy by co-expressing the two
proteins in mammalian cells. CDC25Mm and a HA-tagged
mUBPy (aa 542–1080) were transfected in COS7 cells either
separately or together. 48 h after transfection, lysates were
prepared and processed for immunoprecipitation with anti-HA
antibodies. The recovered immunocomplexes were separated
by SDS-PAGE and blotted. The blots were probed with anti-
Ras-GRF1 antibodies and with polyclonal antibodies raised
against mUBPy. Fig. 5A shows that CDC25Mm was coimmuno-
precipitated only from extracts obtained by cells expressing
both CDC25Mm and HA-mUBPy (lane 3) but not from extracts
of cells transfected with CDC25Mm alone or with HA-mUBPy
alone (lanes 1–2). Aliquots of the same total cell lysates were
loaded in the same gel to check the expression of CDC25Mm
(lane 4), HA-mUBPy (lane 5), and both proteins in cotrans-
fected cells (lane 6). This experiment clearly demonstrates an
in vivo interaction between CDC25Mm and mUBPy. Interest-
ingly the amount of total CDC25Mm protein found in COS7 cells
lysates increased when the mUBPy was co-expressed, suggest-
ing a potential ability of mUBPy to regulate the levels of
CDC25Mm.
To test if the human homolog hUBPy is also able to interact
in vivo with CDC25Mm, we performed similar cotransfection
experiments. Briefly Hek-293 cells were cotransfected with
pCDN3-RasGRF1 and pCDNA3-hUBPy, and then the cell ly-
sates were immunoprecipitated with anti-mUPBy antibodies
and immunoblotted with anti-GRF1 antibodies. As shown in
Fig. 5B, CDC25Mm was coimmunoprecipitated only if hUBPy
was expressed; this indicates that the human homolog is also
able to interact with CDC25Mm. When the same filter was
probed with anti-mUBPy antibodies, a strong band was de-
tected in extracts of cells transfected with hUBPy, whereas a
weak immunoreactive band was also detected in cells not
treated with pCDNA3-hUBPy, which is likely due to endoge-
nous hUBPy protein.
CDC25Mm Is Ubiquitinated in Vivo and mUBPy Decreases Its
Level of Ubiquitination—As a general rule, regulatory proteins
are subjected to a fast turnover, and this is expected to be the
case also for the Ras exchange factors. At our knowledge, no
data regarding the turnover of CDC25Mm/RasGRF1 have been
so far reported in the literature, although RasGRF1 is known to
contain a PEST motif (4). However, it has been recently shown
that RasGRF2, a protein closely related to RasGRF1, is ubiq-
uitinated and is likely degraded by the 26 S proteasome (24); in
addition the ubiquitous mammalian Ras GEF, hSos2, is also
rapidly degraded through an ubiquitination step (25). Since we
found an interaction between CDC25Mm and a deubiquitinat-
ing enzyme (mUBPy), it is reasonable to suppose that
FIG. 4. In vitro interaction of mUBPy (aa 542–660) with the
N-terminal domain of CDC25Mm (aa 1–625). COS7 cells transfected
with pHC21 vector, expressing the N-terminal region of CDC25Mm (aa
1–625) (5),(5 g/100-mm plate), or untransfected COS7 cells were lysed
with HGNT buffer. Lysates were incubated with glutathione-Sepharose
resin loaded with either GST-mUBPy542–660 or GST alone as described
(see “Experimental Procedures”). Protein bound to the resin was recov-
ered and processed for Western blot analysis with anti Ras-GRF1
antibodies. A, Western blot analysis of protein bound to glutathione-
Sepharose beads coupled to GST-mUBPy542–660 (lanes 1 and 3) or GST
alone (lanes 2 and 4). Lanes 1 and 2, control COS7 cells; lanes 3 and 4,
extracts of COS7 cells expressing CDC25Mm 1–625. B, immunodetection
of CDC25Mm1–625 on extracts of COS7 cells. Lane 1, total cell protein
(lysis in RIPA buffer) of control COS7 cells; lane 2, total cell protein of
COS7 cells expressing CDC25Mm1–625; lane 3, lysis buffer (HGNT) ex-
tract of COS7 cells expressing CDC25Mm1–625. The arrows indicate the
70-kDa band expected for CDC25Mm1–625. IP, immunoprecipitate.
FIG. 5. In vivo interaction between CDC25Mm and mUBPy
and hUBPy. A, COS7 cells were transfected with 4 g/100 mm plate of
the indicated vectors (GRF1, pCDNA3-CDC25Mm expressing the full-
length CDC25Mm protein; mUBPy, pCDNA3-mUBPy-HA expressing
mUBPy542–1080 tagged with HA epitope) using pCDNA3 when required
to keep the total DNA to 8 g/plate. After 48 h, cells were harvested and
lysed in HGNT buffer, and lysates were immunoprecipitated with an-
ti-HA antibodies. Immunoprecipitated proteins (IPP) and equal ali-
quots of cleared total lysates (30 l) were separated by SDS-PAGE,
blotted, and probed with either anti-GRF1 antibodies or anti-mUBPy
antibodies. B, Hek-293 cells were transfected with 4 g/100-mm plate of
the indicated vectors (GRF1, pCDNA3-CDC25Mm expressing the full-
length CDC25Mm protein; hUBPy, pCDNA3-hUBPy expressing hUBPy
(12)) using pCDNA3 when required to keep the total DNA to 8 g/plate.
After 48 h, cells were harvested and lysed in HGNT buffer, and lysates
were immunoprecipitated with anti-mUBPy antibodies. Immunopre-
cipitated proteins were separated by SDS-PAGE, blotted, and probed
with either anti-GRF1 antibodies or anti-mUBPy antibodies.
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CDC25Mm could be ubiquitinated and then rapidly degraded.
To assay in vivo the ubiquitination of CDC25Mm, we cotrans-
fected Hek-293 cells with pCDNA3-RasGRF1 and HA-ubiq-
uitin vector (HA-Ub) (26). The epitope-tagged ubiquitin can be
correctly conjugated in vivo to cellular proteins, which then
become targets for proteolytic cleavage (26). The HA-ubiquitin
allows a good quantitative and sensitive detection of ubiquiti-
nation of proteins either by immunoblotting or immunoprecipi-
tation with anti-HA monoclonal antibodies (12, 26).
As shown in Fig. 6A, immunoprecipitation with anti-Ras-
GRF1 antibodies and immunoblotting with anti-HA allows the
detection of high molecular weight HA-immunoreactive spe-
cies, indicating that CDC25Mm/Ras-GRF1 is ubiquitinated un-
der our experimental conditions.
In other experiments, we cotransfected Hek-293 cells with
pCDNA3-RasGRF, HA-Ub, and also with a plasmid expressing
mUBPy (Fig. 6B). The amount of CDC25Mm present in total
extracts clearly decreased in the presence of HA-Ub, suggesting
that an increased availability of ubiquitin might induce a faster
turnover of CDC25Mm protein, whereas a partial recovery was
observed in cotransfection with mUBPy (Fig. 6B, panel 1).
More interestingly, the amount of ubiquitinated CDC25Mm
forms detected with anti-RasGRF1 antibodies on HA-immuno-
precipitates clearly decreased in the presence of mUBPy (Fig.
6B, panel 2, third lane; compare third lane with second lane).
mUBPy Stabilizes the CDC25Mm Protein Expressed in Hek-
293 Cells—The finding that Ras-GRF1/CDC25Mm is ubiquiti-
nated in vivo strongly suggests that this protein may be rapidly
degraded. To measure the stability of the protein, Hek-293 cells
transfected with a vector expressing CDC25Mm were metabol-
ically labeled and subjected to a pulse-chase analysis (Fig. 7).
The apparent half-life of CDC25Mm was about 5–6 h, thus
confirming that this protein is unstable, at least in our exper-
imental conditions.
In parallel experiments, we cotransfected Hek-293 cells with
plasmids expressing CDC25Mm and mUBPy or with a vector
expressing the antisense of hUBPy (12). The latter was used
because Naviglio et al. (12) showed that the cDNA of hUBPy
cloned in the antisense orientation increased protein ubiquiti-
nation, likely by interfering with the expression of endogenous
hUBPy that it is present in most human cell lines and also in
Hek-293 (Fig. 2).
Clearly the expression of mUBPy stabilized the CDC25Mm
protein (Fig. 7), the half-life increases to more than 9 h,
whereas the expression of antisense of hUBPy further destabi-
lized the protein (Fig. 7). These data strongly support the
hypothesis that mUBPy (and its homolog hUBPy) can regulate
the turnover of CDC25Mm.
DISCUSSION
We started this work with the aim to isolate and identify
regulatory proteins able to interact with the large N-terminal
part of the brain-specific Ras exchange factor CDC25Mm (Ras-
GRF1). At the moment our results partially fulfill this purpose
because we have identified a CDC25Mm interacting protein, a
deubiquitinating enzyme called mUBPy, highly homologous to
the human hUBPy as described by Naviglio et al. (12).
At first glance, a deubiquitinating enzyme should not be
directly involved in signal transduction mechanisms, but actu-
ally there is increasing evidence in the literature that deubiq-
uitinases may play relevant roles in several pathways control-
ling growth and/or differentiation. In fact the deubiquitinating
enzymes are thought to act also through the stabilization of
some key components of the pathway, counterbalancing the
activity of specific ubiquitinating factor(s) (27). It is worthwhile
to mention that the faf gene product, involved in eye develop-
FIG. 6. In vivo ubiquitination of CDC25Mm. Hek-293 cells
were cotransfected with the different plasmids (RasGRF1,
pCDNA3-CDC25Mm expressing the full-length CDC25Mm; HA-Ubi,
a pCDNA3 vector expressing HA-tagged ubiquitin; mUBPy,
pCDNA3-mUBPy expressing the full-length mUPBy). 2 g of each
plasmid were used, keeping a total of 6 g of DNA/60-mm dish with the
empty pCDNA3 vector if required. Cells were lysed in RIPA buffer after
48 h. A, equal amounts of protein lysates immunoprecipitated with anti
GRF1 antibodies, separated by SDS-PAGE, blotted, and probed with
anti-GRF1 or anti-Ha antibodies. B, panel 1, equal amounts of total
proteins (30 g) separated by SDS-PAGE, blotted, and probed with
anti-GRF1 antibodies. The arrow indicates the 140-kDa CDC25Mm pro-
tein. Panel 2, equal amounts of the same lysates used for panel 1
immunoprecipitated with anti-HA antibodies and probed with anti-
GRF1 antibodies. A diffuse band corresponding to ubiquitinated
CDC25Mm species with an apparent molecular size of 150–160 kDa is
evident in the second lane and barely detectable in the third lane.
FIG. 7. Stability of CDC25Mm protein expressed in Hek-293
cells. Hek-293 cells were transfected with pCDNA3-CDC25Mm (Con-
trol) or cotransfected with pCDNA3-CDC25Mm and pCDNA3-mUBPy
(mUBPy) or pCDNA3-CDC25Mm and pCDNA3-hUBPy-Antisense
(AS-hUBPy). For transfection, we used 1 g of pCDNA3-CDC25Mm
and 1.5 g of the other plasmids/60-mm dish with the empty pCDNA3
vector if required. After 24 h, cells were labeled for 2 h with [35S]me-
thionine (100 C/dish) and then chased with nonradiolabeled methio-
nine for the number of hours indicated, immunoprecipitated with anti-
RasGRF1, and processed for SDS-PAGE. The gels were
autoradiographed, and the intensity of the specific bands was analyzed
by densitometry. A, relative amount of labeled CDC25Mm immunopre-
cipitated after the chase. Open bar, control; black bar, mUBPy; gray
bar,  AS-hUBPy. B, autoradiography of the immunoprecipitated la-
beled CDC25Mm after 0, 3, 6, and 9 h of chase.
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ment in Drosophila (28). In yeast the UBP3 and UBP4 (named
also DOA4) gene products, are involved in transcriptional reg-
ulation (21, 29), whereas DUB1 protein is required for cell cycle
progression in mouse lymphocytes (30), and UNP deubiquiti-
nase causes tumors in nude mice (31) and is overexpressed in
human small cell lung primary carcinoma (32). These few ex-
amples indicate that deubiquitinating enzymes could interact
in a specific way with a limited variety of substrates. Indeed,
more than 90 deubiquitinating enzymes have been so far iden-
tified (27), and this may explain the marked heterogeneity in
their sequence, apart from the catalytic domain. This peculiar-
ity is present also in mUBPy; in fact its large N-terminal region
(aa 1–700) shows no homology with any other known deubiq-
uitinase with the exception of hUBPy, clearly a human homo-
log of the mouse protein.
Our results indicate that mUBPy interacts both in vitro and
in vivo with CDC25Mm. The region of interaction of mUBPy (aa
540–660) is proline-rich and shows no homology with any other
motif known to mediate protein-protein interactions. A similar
interaction is here shown to occur also between hUBPy and
CDC25Mm. The physiological meaning of this novel interaction
is not yet known; however, here we show that CDC25Mm is
ubiquitinated and that its ubiquitination level can be reduced
by coexpression of mUBPy.
Furthermore the expression of mUBPy stabilizes the
CDC25Mm protein expressed in Hek-293 increasing its half-life.
Therefore we could hypothesize that mUBPy can take part in
the regulation of CDC25Mm turnover in neurons or alterna-
tively play a more general role in the control of proteasome
function as previously suggested (12). Further work is needed
to clarify its specific role.
The mUBPy gene is expressed in several mouse tissues al-
though at a different extent, with a marked expression in the
adult testis. At the protein level, we detected a preferential
expression in the brain and in the testis. The mUBPy protein
was also detected in several other tissues (pancreas, placenta,
etc.) were it was expressed at a much lower level. In addition
we found a good expression of this protein also in mouse
NIH3T3 fibroblasts, in agreement with the data of Naviglio et
al. (12), who found the human hUBPy in most human cell lines.
The pattern of mUBPy expression in mouse tissues is not
unusual because several gene products have been found to be
specifically or predominantly expressed in brain and testis (33),
including another deubiquitinating enzyme belonging to the
family of ubiquitin C-terminal hydrolases, UCH-L1 (34). Pre-
liminary results2 indicate that mUBPy is expressed in the
germ cell component of the testis and that it is still present in
mature spermatozoa.
On the whole, our results suggest that mUBPy may be in-
volved in different deubiquitinating processes in the different
tissues. For example, in the tissues and cell lines where
mUBPy is expressed at a low level, the protein could partici-
pate in the deubiquitination processes of proteasome sub-
strates (12), whereas in the tissues where mUBPy is strongly
expressed (brain and testis), it could exert a more specialized
function through its interaction with specific substrates. One of
these substrates can reasonably be the brain-specific Ras ex-
change factor CDC25Mm/Ras-GRF1.
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